Breaking Biotech
Drug development. Clinical data. Biotech investing.
Independent analysis of clinical trials, biotech companies, and the events that move them.
Latest Analysis
-
120 – Biotech Wrap Up Week Ending Oct 23, 2026
$MRNA $QGEN $NAUT $IAM
Recent Analysis
-
119 – $IVA: Can Lanifibranor Deliver in Phase 3 MASH?
Inventiva is approaching one of the most important MASH readouts of the year with NATiV3, its pivotal Phase 3 trial of Lanifibranor in F2/F3 MASH. In this episode, I break…
-
118 – Biotech Wrap Up Week Ending Oct 9, 2026
$CRBU $LLY $MRNA
-
117 – Biotech Wrap Up Week Ending Oct 2, 2026
$KOD $BEAM $NKTR
